Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc (SNDX) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 280 transactions totaling $54.2M, demonstrating a bearish sentiment with -$49.5M in net insider flow. The most recent transaction on Feb 9, 2026 involved a sale of 3,410 shares valued at $71.7K.
SNDX Insider Activity Summary
Who Is Buying SNDX Stock?
No significant insider buying has been recorded for SNDX in the recent period.
Who Is Selling SNDX Stock?
No significant insider selling has been recorded for SNDX in the recent period.
Is Syndax Pharmaceuticals Inc Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SNDX is bearish with an Insider Alignment Score of 4/100 and a net flow of -$49.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
SNDX Frequently Asked Questions
Understanding SNDX Insider Activity
Insider trading at Syndax Pharmaceuticals Inc (SNDX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading SNDX stock, having executed 280 transactions in the past 90 days. The most active insider is Briggs Morrison (Executive), who has made 56 transactions totaling $36.6M.
Related Tools
Track Syndax Pharmaceuticals Inc Insider Activity
Get notified when executives and directors at SNDX file new Form 4 transactions